Yiviva
New York
About Yiviva
Yiviva develops medicines that improve longevity by preventing, treating, and curing complex, aging-associated diseases. It treats cancer, chronic diseases, and inflammatory diseases. Yiviva improves patient outcomes through a sophisticated multi-targeted approach that treats the entire person as a system.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2018)
- Website: yiviva.com
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/yiviva-129071 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.